Walleye Capital’s LakeShore Biopharma Warrants LSBPW Stock Holding History

Walleye Capital’s Portfolio LSBPW Stock Details LSBPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-95,030	Closed	-$3.79K	–	5259
2025 Q2	$3.79K	Hold	95,030	–	–	﹤0.01%	4365
2025 Q1	$3.92K	Hold	95,030	–	–	﹤0.01%	4111
2024 Q4	$7.54K	Sell	95,030 -4,875	-5%	-$251	﹤0.01%	4602
2024 Q3	$6.6K	Hold	99,905	–	–	﹤0.01%	4967
2024 Q2	$8.79K	Hold	99,905	–	–	﹤0.01%	5248
2024 Q1	$7.15K	Hold	99,905	–	–	﹤0.01%	5107
2023 Q4	$3.8K	Hold	99,905	–	–	﹤0.01%	4680
2023 Q3	$4.12K	Hold	99,905	–	–	﹤0.01%	4620
2023 Q2	$4.7K	Hold	99,905	–	–	﹤0.01%	4037
2023 Q1	$15.6K	Buy	+99,905	New	+$15.1K	﹤0.01%	3457

Other funds holding LSBPW

HIM

HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.78% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Walleye Capital's LSBPW Position: Q3 2025 in Review

Walleye Capital sold out of LakeShore Biopharma Warrants (LSBPW) in Q3 2025, closing a stake of 95,030 shares — an estimated $3.79K sold.

Walleye Capital first reported a position in LSBPW in Q1 2023 and held it in 10 quarters. The position peaked at $15.6K in Q1 2023. 3 funds tracked by Wall St. Rank hold LSBPW as of Q3 2025.

Walleye Capital reported no remaining LakeShore Biopharma Warrants position as of Q3 2025 after selling out during the quarter.
Walleye Capital sold 95,030 LakeShore Biopharma Warrants shares in Q3 2025, an estimated $3.79K.
Walleye Capital first reported a position in LakeShore Biopharma Warrants in Q1 2023 and held it in 10 quarters.
Walleye Capital's LakeShore Biopharma Warrants position peaked at $15.6K in Q1 2023.
3 funds tracked by Wall St. Rank held LakeShore Biopharma Warrants as of Q3 2025.

Based on Walleye Capital's 13F filing for Q3 2025, filed 14 Nov 2025.